daclatasvir
Daclatasvir is used only in combination therapy for the treatment of hepatitis C genotype 1, 3, or 4 infections.. Reference standards of Daclatasvir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => (2R)-2-(Methoxycarbonylamino)-3-methylbutanoic Acid
[catalogue_number] => PA 04 94510
[category_ids] => ,79,92,
[chemical_name] =>
[weight] => 175.18
[form] => C7H13NO4
[cas] => 171567-86-5
[pslug] => 171567-86-5-2r-2-methoxycarbonylamino-3-methylbutanoic-acid-pa0494510
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(2R)-2-(Methoxycarbonylamino)-3-methylbutanoic Acid
Catalogue No.:PA 04 94510
Molecular Formula : C7H13NO4
Molecular Weight : 175.18